Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


UroGen Pharma Reports Final Topline Results From OPTIMA II Phase 2b Trial Evaluating Efficacy And Safety Of UGN-102


RTTNews | Nov 17, 2020 08:04AM EST

08:04 Tuesday, November 17, 2020 (RTTNews) - UroGen Pharma Reports Final Topline Results From OPTIMA II Phase 2b Trial Evaluating Efficacy And Safety Of UGN-102

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC